Efficacy, safety, and adherence of tocilizumab therapy in elderly patients with rheumatoid arthritis: A real-world observational study
Objective: We evaluated the efficacy, safety, and drug survival rate of tocilizumab in the elderly patients with rheumatoid arthritis (RA). Methods: This study was conducted in 108 RA patients who started tocilizumab between 2008 and 2018. The patients were divided into a young group (<65 years)...
Enregistré dans:
Auteurs principaux: | Yoshinobu Nakao, Yu Funakubo Asanuma, Takuma Tsuzuki Wada, Mayumi Matsuda, Hiroaki Yazawa, Yoshihiro Yoshida, Akira Todoriki, Ayumi Shintani, Toshihide Mimura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/40bf5bde4d984b6b9bd4dfa2440ba935 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Review of tocilizumab in the treatment of rheumatoid arthritis
par: Yasuaki Okuda
Publié: (2008) -
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
par: Mahamid M, et autres
Publié: (2011) -
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
par: Sho Mokuda, et autres
Publié: (2013) -
Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
par: Sato T, et autres
Publié: (2014) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
par: Tanaka T, et autres
Publié: (2014)